Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-08-04

Clinical Trial Results: Reduction of Opioid Dose Using Conditioning & Open-Label Placebo (COLP) in Intensive Rehabilitation [Phase 2]

View source ↗

Summary

Phase 2 trial results on using conditioning and open-label placebo (COLP) to reduce opioid dose in intensive rehabilitation for spinal cord injuries and polytra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLP (conditioning & open-label placebo)

Snippet

Sponsor: Spaulding Rehabilitation Hospital | Conditions: Spinal Cord Injuries, Polytrauma | Phase 2 | Status: COMPLETED | Results posted: 2026-08-04